留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

呼吸机相关性肺炎

刘洋 孟彦苓 杜斌

刘洋, 孟彦苓, 杜斌. 呼吸机相关性肺炎[J]. 协和医学杂志, 2010, 1(1): 103-107.
引用本文: 刘洋, 孟彦苓, 杜斌. 呼吸机相关性肺炎[J]. 协和医学杂志, 2010, 1(1): 103-107.

呼吸机相关性肺炎

详细信息
    通讯作者:

    杜斌 电话:010-65295036, E-mail:dubin98@gmail.com

  • 中图分类号: R563.1;R605.973

  • [1] Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee [J]. JAMA, 1995, 274: 639-644. doi:  10.1001/jama.1995.03530080055041
    [2] Heyland DK, Cook DJ, Crifth L, et al. The atributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group [J]. Am J Respir Crit Care Med, 1999, 159:1249-1256. doi:  10.1164/ajrccm.159.4.9807050
    [3] Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: results of a matched casecontrol study of ICU patients [J]. Am J Respir Crit Care Med, 1998, 157:1151-1158. doi:  10.1164/ajrccm.157.4.9701129
    [4] Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies[J]. Thorax, 1999, 54: 867-873. doi:  10.1136/thx.54.10.867
    [5] Heyland D, Ewig S, Torres A. Pro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator associated pneumonia[J]. Crit Care, 2002, 6:117120.
    [6] Canadian Critical Care Trials Group. Arandomizedrial of diagnostic techniques for ventilator-associated pneumonia[J]. N Engl J Med, 2006, 355: 2619-2630. doi:  10.1056/NEJMoa052904
    [7] Jackson SR, Emnst NE, Mueller EW, et al. Utility of bilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia in critically ill surgical patients[J]. Am J Surg, 2008, 195: 159-163. doi:  10.1016/j.amjsurg.2007.09.030
    [8] Mentec H, May-Michelangeli L, Rabbat A, et al. Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia. A multicentre prospective study[J]. Intensive Care Med, 2004, 30:1319-1326. doi:  10.1007/s00134-004-2284-7
    [9] Leo A, Galindo-Galindo J, Folch E, et al. Comparison of bronchoscopic bronchoalveolar lavage vs blind lavage with a modified nasogastric tube in the etiologic diagnosis of ventilator-associated pneumonia[J]. Med Intensiva, 2008, 32: 115-120. doi:  10.1016/S0210-5691(08)70921-5
    [10] Flanagan PG, Findlay GP, Magee JT, et al. The diagnosis of ventilator-associated pneumonia using nonbronchoscopic, nondirected lung lavages[J]. Intensive Care Med, 2000, 26: 20-30. doi:  10.1007/s001340050007
    [11] Lorente L, Lecuona M, Jimeńez A, et al. Ventilator associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial[J]. Crit Care, 2006, 10:R116. doi:  10.1186/cc5009
    [12] Siempos Ⅱ, Vardakas KZ, Kopterides P, et al. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a metaanalysis of randomized controlled trials[J]. Crit Care Med, 2007, 35: 2843-2851.
    [13] Siempos Ⅱ, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia [J]. Br J Anaesth, 2008, 100: 299306.
    [14] Subirana M, Sola I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients[J]. Cochrane Database Syst Rev, 2007: CD004581.
    [15] Lindgren S. Regional lung derecruitment after endotracheal suction during volumeor pressure-controlled ventilation: a study using electric impedance tomography[J]. Intensive Care Med, 2007, 33:172-180. doi:  10.1007/s00134-006-0425-x
    [16] Valle's J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia [J]. Ann Intern Med, 1995, 122:179-186. doi:  10.7326/0003-4819-122-3-199502010-00004
    [17] Dezfulian C, Shojania K, Collard HR, et al. Sublottie secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis[J]. AmJ Med, 2005, 118:11-18. doi:  10.1016/j.amjmed.2004.07.051
    [18] Dullenkopf A, Gerber A, Weiss M. Fluid leakage past tracheal tube cuffis: evaluation of the new Microcuff endotracheal tube[J]. Intens Care Med, 2003, 29: 1849-1853. doi:  10.1007/s00134-003-1933-6
    [19] Poelaert J, Depuydt P, De Wolf A, et al. Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: a pilot study[J]. J Thorac Cardiovasc Surg, 2008, 135: 771-776. doi:  10.1016/j.jtcvs.2007.08.052
    [20] Lorente L, Lecuona M, Jime'nez A, et al. Influence of an endotracheal tube with polyurethane cuff and sublottic secretion drainage on pneumonia[J]. Am J Respir Crit Care Med, 2007, 176:1079-1083. doi:  10.1164/rccm.200705-761OC
    [21] Smulders K, van der Hoeven H, Weers-PothoffI, et al. A randomized clinical trial of intermittent sublottic secretion drainage in patients receiving mechanical ventilation[J]. Chest, 2002, 121: 858-862. doi:  10.1378/chest.121.3.858
    [22] Dragoumanis CK, Vretzakis GI, Papaioannou VE, et al. Investigating the failure to aspirate sublottic secretions with the Evac endotracheal tube[J]. Anesth Analg, 2007, 105: 1083-1085. doi:  10.1213/01.ane.0000278155.19911.67
    [23] Inglis TJ, Lim TM, Ng ML, et al. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation[J]. Chest, 1995, 108: 1049-1052. doi:  10.1378/chest.108.4.1049
    [24] Kollef MH, Afessa B, Anzueto A, NASCENT Investigation Group. Silvercoated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial[J]. JAMA, 2008, 300: 805-813.
    [25] Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin[J]. J Infect Dis, 1996, 173: 418-424. doi:  10.1093/infdis/173.2.418
    [26] Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilatorassociated pneumonia[J]. Chest, 2002, 122: 262-268. doi:  10.1378/chest.122.1.262
    [27] Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit ICU-Acquired Pneumonia Study Group[J]. Intens Care Med, 1996, 22: 387-394. doi:  10.1007/BF01712153
    [28] Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis[J]. Crit Care, 2008, 23: 91-100. doi:  10.1016/j.jcrc.2007.08.007
    [29] Parker CM, Kutsogiannis J, Muscedere J, et al. Ventilatorassociated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes[J]. J Crit Care, 2008, 23:1826.
    [30] Sanders KM, Adhikari NK, Friedrich JO, et al. Previous. cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial[J]. J Crit Care, 2008, 23: 58-63. doi:  10.1016/j.jcrc.2008.01.009
    [31] Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia[J]. Intens Care Med, 2008, 34: 675-682. doi:  10.1007/s00134-007-0953-z
    [32] Joffe AR, Muscedere J, Marshall JC, et al. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study[J]. J Crit Care, 2008, 23: 82-90. doi:  10.1016/j.jcrc.2007.12.006
    [33] Chastre J, Wolf M, Fagon JY, et al. Comparison of8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial[J]. JAMA, 2003, 290: 2588-2598. doi:  10.1001/jama.290.19.2588
    [34] Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate[J]. Intens Care Med, 2007, 33: 1533-1540. doi:  10.1007/s00134-007-0619-x
    [35] Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy[J]. Crit Care Med, 2007, 35: 1888-1895. doi:  10.1097/01.CCM.0000275389.31974.22
    [36] Heyland DK, Dodek P, Muscedere J, et al Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia[J]. Crit Care Med, 2008, 36: 737-744. doi:  10.1097/01.CCM.0B013E31816203D6
  • 加载中
计量
  • 文章访问数:  232
  • HTML全文浏览量:  98
  • PDF下载量:  13
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-04-14
  • 刊出日期:  2010-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!